United States Post-Traumatic Stress Disorder (PTSD) Market and Competitive Landscape, 2019 Report - ResearchAndMarkets.com

The "United States Post-Traumatic Stress Disorder (PTSD) Market and Competitive Landscape, 2019 Report" report has been added to ResearchAndMarkets.com's offering.

This latest research provides comprehensive insights into Post-Traumatic Stress Disorder pipeline products, Post-Traumatic Stress Disorder epidemiology, Post-Traumatic Stress Disorder market valuations and forecast, Post-Traumatic Stress Disorder drugs sales and competitive landscape in the US.

The research is classified into seven sections - Post-Traumatic Stress Disorder treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope

• Post-Traumatic Stress Disorder pipeline: Find out the products in clinical trials for the treatment of Post-Traumatic Stress Disorder by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
• Post-Traumatic Stress Disorder epidemiology: Find out the number of patients diagnosed (prevalence) with Post-Traumatic Stress Disorder in the US
• Post-Traumatic Stress Disorder drugs: Identify key products marketed and prescribed for Post-Traumatic Stress Disorder in the US, including trade name, molecule name, and company
• Post-Traumatic Stress Disorder drugs sales: Find out the sales revenues of Post-Traumatic Stress Disorder drugs in the US
• Post-Traumatic Stress Disorder market valuations: Find out the market size for Post-Traumatic Stress Disorder drugs in 2018 in the US. Find out how the market advanced from 2014 and forecast to 2024
• Post-Traumatic Stress Disorder drugs market share: Find out the market shares for key Post-Traumatic Stress Disorder drugs in the US

Benefits of this Research

• Support monitoring and reporting national Post-Traumatic Stress Disorder market analysis and sales trends
• Track competitor drugs sales and market share in the US Post-Traumatic Stress Disorder market
• Track competitive developments in Post-Traumatic Stress Disorder market and present key issues and learnings
• Synthesize insights for Post-Traumatic Stress Disorder market and products to drive business performance
• Answer key business questions about the Post-Traumatic Stress Disorder market
• Evaluate commercial market opportunity assessment, positioning, and segmentation for Post-Traumatic Stress Disorder products
• Supports decision making in R&D to long term marketing strategies

Key Topics Covered

1) Post-Traumatic Stress Disorder Treatments

2) Post-Traumatic Stress Disorder Pipeline

3) US Post-Traumatic Stress Disorder Epidemiology

4) Marketed Drugs for Post-Traumatic Stress Disorder in US

5) US Post-Traumatic Stress Disorder Market Size and Forecast

6) US Post-Traumatic Stress Disorder Products Sales and Forecast

7) US Post-Traumatic Stress Disorder Market Competitive Landscape

8) Methodology

List of Tables

1. Post-Traumatic Stress Disorder Phase 3 Clinical Trials, 2019

2. Post-Traumatic Stress Disorder Phase 2 Clinical Trials, 2019

3. Post-Traumatic Stress Disorder Phase 1 Clinical Trials, 2019

4. Post-Traumatic Stress Disorder Epidemiology, US, 2014 - 2024

5. Marketed Drugs for Post-Traumatic Stress Disorder, US, 2018

6. Post-Traumatic Stress Disorder Market Size and Forecast ($), US, 2014 - 2024

7. Post-Traumatic Stress Disorder Product Sales ($), US, 2014 - 2024

List of Figures

1. Post-Traumatic Stress Disorder Epidemiology, US, 2014 - 2024

2. Post-Traumatic Stress Disorder Market Size and Forecast ($), US, 2014 - 2024

3. Post-Traumatic Stress Disorder Products Market Share (%), US, 2018

For more information about this report visit https://www.researchandmarkets.com/r/5s53gd

View source version on businesswire.com: https://www.businesswire.com/news/home/20190626005789/en/